| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 322 | 2023 | 12261 | 9.500 |
Why?
|
| Genetic Predisposition to Disease | 354 | 2023 | 17446 | 7.790 |
Why?
|
| Polymorphism, Single Nucleotide | 394 | 2023 | 15519 | 7.530 |
Why?
|
| Breast Neoplasms | 178 | 2023 | 20822 | 4.470 |
Why?
|
| Models, Genetic | 59 | 2021 | 3494 | 4.100 |
Why?
|
| Genetic Variation | 75 | 2022 | 6544 | 3.040 |
Why?
|
| Prostatic Neoplasms | 98 | 2023 | 11124 | 3.020 |
Why?
|
| Case-Control Studies | 253 | 2023 | 21746 | 3.020 |
Why?
|
| Genetic Loci | 59 | 2022 | 2575 | 2.950 |
Why?
|
| Pancreatic Neoplasms | 54 | 2023 | 5256 | 2.700 |
Why?
|
| Genotype | 170 | 2023 | 12951 | 2.650 |
Why?
|
| Quantitative Trait Loci | 45 | 2023 | 2019 | 2.580 |
Why?
|
| Linkage Disequilibrium | 55 | 2022 | 1997 | 2.030 |
Why?
|
| Multifactorial Inheritance | 26 | 2023 | 1194 | 1.940 |
Why?
|
| Mendelian Randomization Analysis | 30 | 2023 | 967 | 1.910 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2020 | 544 | 1.750 |
Why?
|
| Risk Factors | 228 | 2023 | 72290 | 1.560 |
Why?
|
| Chromosome Mapping | 39 | 2022 | 4740 | 1.520 |
Why?
|
| Alleles | 65 | 2023 | 6933 | 1.450 |
Why?
|
| Genome, Human | 42 | 2022 | 4420 | 1.390 |
Why?
|
| Humans | 677 | 2024 | 744343 | 1.350 |
Why?
|
| Vitamin D | 22 | 2020 | 3223 | 1.320 |
Why?
|
| Female | 451 | 2024 | 380194 | 1.280 |
Why?
|
| Receptors, Estrogen | 29 | 2023 | 2187 | 1.270 |
Why?
|
| Haplotypes | 36 | 2022 | 2779 | 1.270 |
Why?
|
| Endometrial Neoplasms | 15 | 2023 | 1353 | 1.240 |
Why?
|
| Models, Statistical | 21 | 2020 | 5102 | 1.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 38 | 2023 | 11725 | 1.220 |
Why?
|
| Genes | 6 | 2015 | 1893 | 1.160 |
Why?
|
| Body Mass Index | 54 | 2023 | 12720 | 1.090 |
Why?
|
| Germ-Line Mutation | 16 | 2023 | 1788 | 1.080 |
Why?
|
| Telomere | 11 | 2019 | 910 | 1.060 |
Why?
|
| Risk | 61 | 2023 | 9687 | 1.060 |
Why?
|
| Middle Aged | 286 | 2024 | 213383 | 1.060 |
Why?
|
| ABO Blood-Group System | 11 | 2023 | 367 | 1.020 |
Why?
|
| Environment | 8 | 2015 | 1124 | 1.020 |
Why?
|
| Genetic Markers | 19 | 2018 | 2634 | 0.990 |
Why?
|
| Glaucoma, Open-Angle | 11 | 2021 | 706 | 0.980 |
Why?
|
| Ovarian Neoplasms | 18 | 2023 | 4838 | 0.980 |
Why?
|
| Odds Ratio | 61 | 2021 | 9849 | 0.960 |
Why?
|
| Gene Frequency | 37 | 2022 | 3588 | 0.930 |
Why?
|
| Male | 321 | 2024 | 350118 | 0.900 |
Why?
|
| Carcinoma, Pancreatic Ductal | 8 | 2023 | 1634 | 0.900 |
Why?
|
| Aged | 209 | 2024 | 163280 | 0.880 |
Why?
|
| Smoking | 30 | 2021 | 8987 | 0.880 |
Why?
|
| Genomics | 23 | 2022 | 5720 | 0.870 |
Why?
|
| Fatty Acid Desaturases | 4 | 2018 | 102 | 0.870 |
Why?
|
| Genetic Association Studies | 28 | 2021 | 2703 | 0.850 |
Why?
|
| Body Height | 11 | 2022 | 1577 | 0.830 |
Why?
|
| Computer Simulation | 18 | 2021 | 6196 | 0.810 |
Why?
|
| BRCA1 Protein | 11 | 2023 | 1149 | 0.810 |
Why?
|
| Genetic Testing | 16 | 2023 | 3444 | 0.780 |
Why?
|
| Risk Assessment | 57 | 2023 | 23338 | 0.770 |
Why?
|
| Germ Cells | 7 | 2023 | 631 | 0.770 |
Why?
|
| Phenotype | 58 | 2022 | 16365 | 0.770 |
Why?
|
| Insulin-Like Growth Factor I | 12 | 2017 | 2015 | 0.750 |
Why?
|
| Europe | 23 | 2022 | 3339 | 0.750 |
Why?
|
| Nurses | 15 | 2019 | 2461 | 0.750 |
Why?
|
| Molecular Epidemiology | 8 | 2019 | 468 | 0.720 |
Why?
|
| Colorectal Neoplasms | 26 | 2020 | 6773 | 0.710 |
Why?
|
| Chromosomes, Human, Pair 5 | 9 | 2017 | 403 | 0.700 |
Why?
|
| Metabolomics | 8 | 2023 | 1484 | 0.700 |
Why?
|
| Adenocarcinoma | 16 | 2021 | 6364 | 0.700 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 4 | 2018 | 94 | 0.680 |
Why?
|
| Adult | 183 | 2023 | 214055 | 0.680 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 9 | 2016 | 424 | 0.670 |
Why?
|
| Metabolome | 5 | 2023 | 895 | 0.660 |
Why?
|
| Principal Component Analysis | 9 | 2015 | 940 | 0.660 |
Why?
|
| Inheritance Patterns | 7 | 2019 | 340 | 0.660 |
Why?
|
| Skin Neoplasms | 22 | 2020 | 5686 | 0.650 |
Why?
|
| Telomerase | 9 | 2018 | 730 | 0.650 |
Why?
|
| Prospective Studies | 85 | 2024 | 53288 | 0.640 |
Why?
|
| Multivariate Analysis | 20 | 2021 | 12245 | 0.640 |
Why?
|
| Disease | 7 | 2017 | 680 | 0.630 |
Why?
|
| Meta-Analysis as Topic | 16 | 2017 | 1344 | 0.630 |
Why?
|
| Venous Thromboembolism | 9 | 2022 | 1671 | 0.620 |
Why?
|
| Chromosomes, Human, Pair 8 | 8 | 2018 | 460 | 0.620 |
Why?
|
| Cohort Studies | 84 | 2022 | 40561 | 0.610 |
Why?
|
| Menarche | 8 | 2019 | 516 | 0.600 |
Why?
|
| Genetics, Population | 8 | 2021 | 934 | 0.590 |
Why?
|
| Carotenoids | 5 | 2021 | 624 | 0.590 |
Why?
|
| Vital Capacity | 2 | 2017 | 925 | 0.580 |
Why?
|
| Polymorphism, Genetic | 20 | 2017 | 4328 | 0.580 |
Why?
|
| Computational Biology | 12 | 2021 | 3521 | 0.580 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2018 | 226 | 0.570 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2016 | 587 | 0.570 |
Why?
|
| Carcinoma, Squamous Cell | 12 | 2020 | 4034 | 0.570 |
Why?
|
| Receptors, Progesterone | 11 | 2022 | 1097 | 0.560 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 1889 | 0.530 |
Why?
|
| Heredity | 2 | 2013 | 154 | 0.520 |
Why?
|
| Forced Expiratory Volume | 3 | 2017 | 1743 | 0.520 |
Why?
|
| Genetic Linkage | 9 | 2013 | 2421 | 0.520 |
Why?
|
| Menopause | 14 | 2023 | 1626 | 0.520 |
Why?
|
| Gonadal Steroid Hormones | 11 | 2017 | 712 | 0.510 |
Why?
|
| Factor XII | 1 | 2014 | 19 | 0.510 |
Why?
|
| Bees | 2 | 2014 | 43 | 0.510 |
Why?
|
| Neoplasms | 25 | 2024 | 21683 | 0.510 |
Why?
|
| Life Style | 6 | 2021 | 3835 | 0.510 |
Why?
|
| Factor XI | 1 | 2014 | 26 | 0.510 |
Why?
|
| Penetrance | 5 | 2016 | 381 | 0.510 |
Why?
|
| Thrombosis | 6 | 2023 | 2968 | 0.510 |
Why?
|
| Genetic Pleiotropy | 6 | 2022 | 182 | 0.500 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2023 | 475 | 0.500 |
Why?
|
| Tobacco Use Disorder | 7 | 2019 | 688 | 0.500 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 711 | 0.500 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2012 | 565 | 0.490 |
Why?
|
| Carcinoma, Basal Cell | 8 | 2019 | 545 | 0.490 |
Why?
|
| BRCA2 Protein | 6 | 2023 | 794 | 0.470 |
Why?
|
| Receptors, Somatostatin | 2 | 2014 | 129 | 0.470 |
Why?
|
| Fatty Acids | 3 | 2018 | 1809 | 0.470 |
Why?
|
| Postmenopause | 14 | 2022 | 2461 | 0.470 |
Why?
|
| Metabolic Networks and Pathways | 8 | 2018 | 783 | 0.470 |
Why?
|
| Adiposity | 7 | 2023 | 1807 | 0.450 |
Why?
|
| Polycystic Ovary Syndrome | 4 | 2022 | 370 | 0.450 |
Why?
|
| Toll-Like Receptor 6 | 2 | 2010 | 28 | 0.450 |
Why?
|
| Molecular Sequence Annotation | 7 | 2021 | 528 | 0.450 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2019 | 3597 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 2 | 7 | 2021 | 326 | 0.440 |
Why?
|
| Genetics, Medical | 3 | 2021 | 338 | 0.440 |
Why?
|
| Gene Expression | 13 | 2023 | 7799 | 0.440 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 3 | 2010 | 55 | 0.440 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 2010 | 216 | 0.430 |
Why?
|
| Mammography | 12 | 2022 | 2476 | 0.420 |
Why?
|
| Logistic Models | 37 | 2021 | 13408 | 0.420 |
Why?
|
| Receptors, Nicotinic | 6 | 2015 | 497 | 0.420 |
Why?
|
| Bayes Theorem | 12 | 2023 | 2309 | 0.410 |
Why?
|
| Ischemic Attack, Transient | 2 | 2014 | 935 | 0.410 |
Why?
|
| Likelihood Functions | 11 | 2017 | 1005 | 0.410 |
Why?
|
| Premenopause | 8 | 2021 | 1033 | 0.410 |
Why?
|
| Carcinoma, Lobular | 4 | 2021 | 484 | 0.410 |
Why?
|
| Intraocular Pressure | 8 | 2019 | 1270 | 0.410 |
Why?
|
| Diabetes Complications | 3 | 2020 | 1359 | 0.400 |
Why?
|
| Aged, 80 and over | 52 | 2022 | 57776 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 2016 | 658 | 0.400 |
Why?
|
| United States | 65 | 2022 | 69872 | 0.400 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2016 | 3920 | 0.390 |
Why?
|
| Sample Size | 11 | 2022 | 845 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2021 | 8428 | 0.390 |
Why?
|
| Signal Transduction | 23 | 2021 | 23403 | 0.380 |
Why?
|
| Epigenomics | 1 | 2016 | 903 | 0.380 |
Why?
|
| Databases, Genetic | 9 | 2020 | 1783 | 0.380 |
Why?
|
| Waist-Hip Ratio | 5 | 2016 | 517 | 0.370 |
Why?
|
| Reproduction | 5 | 2023 | 668 | 0.370 |
Why?
|
| Research Design | 9 | 2022 | 5987 | 0.370 |
Why?
|
| National Cancer Institute (U.S.) | 6 | 2015 | 288 | 0.370 |
Why?
|
| Birth Order | 2 | 2016 | 95 | 0.370 |
Why?
|
| von Willebrand Factor | 1 | 2014 | 669 | 0.370 |
Why?
|
| DNA-Binding Proteins | 15 | 2023 | 9648 | 0.370 |
Why?
|
| Alcohol Drinking | 10 | 2022 | 3966 | 0.360 |
Why?
|
| Neoplasm Proteins | 9 | 2019 | 3703 | 0.360 |
Why?
|
| Chromosomes, Human | 5 | 2017 | 457 | 0.360 |
Why?
|
| Exercise | 5 | 2019 | 5615 | 0.350 |
Why?
|
| Republic of Korea | 2 | 2023 | 539 | 0.350 |
Why?
|
| Obesity | 22 | 2023 | 12745 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2018 | 462 | 0.350 |
Why?
|
| Mutation | 18 | 2023 | 29786 | 0.350 |
Why?
|
| Proportional Hazards Models | 24 | 2021 | 12354 | 0.350 |
Why?
|
| Receptors, Leptin | 4 | 2023 | 360 | 0.350 |
Why?
|
| Genetic Research | 3 | 2011 | 174 | 0.350 |
Why?
|
| Lung Neoplasms | 20 | 2019 | 13102 | 0.350 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 5 | 2019 | 188 | 0.350 |
Why?
|
| Arylamine N-Acetyltransferase | 2 | 2023 | 86 | 0.340 |
Why?
|
| Leptin | 4 | 2023 | 1599 | 0.340 |
Why?
|
| Statistics as Topic | 3 | 2010 | 2373 | 0.340 |
Why?
|
| Environmental Exposure | 6 | 2020 | 4234 | 0.340 |
Why?
|
| Follow-Up Studies | 39 | 2024 | 39050 | 0.340 |
Why?
|
| Esophageal Neoplasms | 3 | 2014 | 1583 | 0.330 |
Why?
|
| Carcinoma | 5 | 2012 | 2375 | 0.330 |
Why?
|
| Siblings | 5 | 2013 | 854 | 0.330 |
Why?
|
| Linear Models | 13 | 2021 | 5952 | 0.330 |
Why?
|
| Estrogen Replacement Therapy | 6 | 2022 | 1203 | 0.330 |
Why?
|
| Leukocytes | 6 | 2019 | 2043 | 0.320 |
Why?
|
| DNA Methylation | 5 | 2020 | 4286 | 0.320 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2022 | 1381 | 0.320 |
Why?
|
| Light | 2 | 2014 | 1374 | 0.320 |
Why?
|
| Mammary Glands, Human | 3 | 2015 | 199 | 0.320 |
Why?
|
| Anti-Mullerian Hormone | 2 | 2022 | 402 | 0.320 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2021 | 1101 | 0.320 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2023 | 2245 | 0.310 |
Why?
|
| Family | 5 | 2018 | 3147 | 0.300 |
Why?
|
| Regression Analysis | 10 | 2018 | 6459 | 0.300 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 1504 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 10 | 2019 | 4462 | 0.290 |
Why?
|
| Cues | 2 | 2014 | 873 | 0.290 |
Why?
|
| Disease Susceptibility | 11 | 2020 | 1782 | 0.290 |
Why?
|
| Estrone | 5 | 2021 | 240 | 0.290 |
Why?
|
| Melanoma | 9 | 2020 | 5510 | 0.290 |
Why?
|
| Hormones | 3 | 2018 | 889 | 0.280 |
Why?
|
| Gallstones | 2 | 2021 | 286 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2011 | 373 | 0.280 |
Why?
|
| Aromatase | 4 | 2012 | 146 | 0.280 |
Why?
|
| Sequence Deletion | 3 | 2021 | 1526 | 0.270 |
Why?
|
| Heterozygote | 9 | 2023 | 2804 | 0.270 |
Why?
|
| Cardiovascular Diseases | 9 | 2023 | 15165 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2020 | 323 | 0.270 |
Why?
|
| Blood Platelets | 5 | 2023 | 2508 | 0.270 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 12072 | 0.270 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 592 | 0.270 |
Why?
|
| Endometriosis | 3 | 2023 | 839 | 0.260 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2020 | 794 | 0.260 |
Why?
|
| Area Under Curve | 4 | 2015 | 1654 | 0.260 |
Why?
|
| Probability | 5 | 2021 | 2505 | 0.260 |
Why?
|
| Early Detection of Cancer | 5 | 2022 | 3086 | 0.260 |
Why?
|
| Prognosis | 32 | 2021 | 29063 | 0.260 |
Why?
|
| Estrogen Receptor beta | 4 | 2011 | 175 | 0.250 |
Why?
|
| Vitamin A | 3 | 2013 | 615 | 0.250 |
Why?
|
| Epidemiologic Research Design | 1 | 2008 | 367 | 0.250 |
Why?
|
| Receptor, Melanocortin, Type 1 | 3 | 2018 | 76 | 0.250 |
Why?
|
| Gene Expression Profiling | 11 | 2020 | 9438 | 0.250 |
Why?
|
| Triglycerides | 4 | 2020 | 2454 | 0.250 |
Why?
|
| ROC Curve | 7 | 2023 | 3527 | 0.240 |
Why?
|
| Rh Isoimmunization | 1 | 2004 | 21 | 0.240 |
Why?
|
| Diet | 15 | 2022 | 7939 | 0.240 |
Why?
|
| Sensitivity and Specificity | 6 | 2014 | 14722 | 0.240 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2014 | 548 | 0.240 |
Why?
|
| Skin Pigmentation | 3 | 2013 | 282 | 0.240 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2010 | 123 | 0.240 |
Why?
|
| Incidence | 17 | 2023 | 20947 | 0.240 |
Why?
|
| Australia | 5 | 2014 | 1170 | 0.240 |
Why?
|
| Alopecia | 2 | 2018 | 382 | 0.240 |
Why?
|
| Age Factors | 19 | 2019 | 18370 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 4803 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2019 | 417 | 0.230 |
Why?
|
| Breast | 6 | 2022 | 1969 | 0.230 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2009 | 489 | 0.230 |
Why?
|
| Receptors, Androgen | 5 | 2014 | 1058 | 0.230 |
Why?
|
| DNA Repair | 5 | 2015 | 2046 | 0.230 |
Why?
|
| Homozygote | 5 | 2015 | 1785 | 0.230 |
Why?
|
| Membrane Proteins | 11 | 2023 | 7880 | 0.230 |
Why?
|
| Artifacts | 2 | 2011 | 1904 | 0.230 |
Why?
|
| False Positive Reactions | 5 | 2021 | 981 | 0.220 |
Why?
|
| Algorithms | 16 | 2023 | 13881 | 0.220 |
Why?
|
| Nevus, Pigmented | 2 | 2018 | 219 | 0.220 |
Why?
|
| Blood Pressure Determination | 2 | 2003 | 634 | 0.220 |
Why?
|
| DNA Copy Number Variations | 3 | 2022 | 1941 | 0.220 |
Why?
|
| Pedigree | 5 | 2019 | 4644 | 0.220 |
Why?
|
| Progesterone | 3 | 2021 | 776 | 0.220 |
Why?
|
| Diabetic Angiopathies | 2 | 2018 | 818 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2019 | 322 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2016 | 197 | 0.220 |
Why?
|
| Fertility | 3 | 2023 | 781 | 0.220 |
Why?
|
| Vitamin D Deficiency | 4 | 2020 | 1343 | 0.210 |
Why?
|
| Fenofibrate | 2 | 2020 | 88 | 0.210 |
Why?
|
| Estrogens | 6 | 2022 | 1566 | 0.210 |
Why?
|
| Lymphoma, B-Cell | 3 | 2020 | 931 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2017 | 793 | 0.210 |
Why?
|
| Feeding Behavior | 6 | 2020 | 3188 | 0.210 |
Why?
|
| Parity | 3 | 2016 | 929 | 0.210 |
Why?
|
| Glycoproteins | 1 | 2010 | 2263 | 0.210 |
Why?
|
| Homocysteine | 4 | 2015 | 647 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 3 | 2013 | 167 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2012 | 3712 | 0.210 |
Why?
|
| Multigene Family | 4 | 2017 | 1102 | 0.210 |
Why?
|
| Age of Onset | 7 | 2021 | 3271 | 0.200 |
Why?
|
| Validation Studies as Topic | 2 | 2020 | 159 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 3 | 2022 | 745 | 0.200 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 484 | 0.200 |
Why?
|
| Epidemiologic Studies | 3 | 2016 | 676 | 0.200 |
Why?
|
| Software | 9 | 2017 | 4443 | 0.200 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2021 | 27 | 0.200 |
Why?
|
| Depression | 7 | 2023 | 7766 | 0.200 |
Why?
|
| Biometry | 1 | 2004 | 558 | 0.200 |
Why?
|
| Pregnanediol | 1 | 2021 | 18 | 0.200 |
Why?
|
| Adiponectin | 4 | 2023 | 1100 | 0.200 |
Why?
|
| Medical History Taking | 3 | 2021 | 783 | 0.200 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2017 | 1596 | 0.200 |
Why?
|
| Ovary | 3 | 2021 | 981 | 0.200 |
Why?
|
| Smoking Cessation | 4 | 2015 | 2071 | 0.190 |
Why?
|
| Colonic Neoplasms | 4 | 2020 | 2541 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 5867 | 0.190 |
Why?
|
| Weight Loss | 2 | 2024 | 2622 | 0.190 |
Why?
|
| Sex Factors | 11 | 2020 | 10397 | 0.190 |
Why?
|
| Mosaicism | 2 | 2015 | 441 | 0.190 |
Why?
|
| Cation Transport Proteins | 1 | 2023 | 327 | 0.190 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2021 | 115 | 0.190 |
Why?
|
| Cholesterol, HDL | 4 | 2022 | 1814 | 0.190 |
Why?
|
| Dietary Fats | 5 | 2019 | 2017 | 0.190 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2015 | 129 | 0.180 |
Why?
|
| Carcinogens, Environmental | 1 | 2020 | 67 | 0.180 |
Why?
|
| Random Allocation | 3 | 2018 | 2429 | 0.180 |
Why?
|
| Models, Theoretical | 5 | 2021 | 3589 | 0.180 |
Why?
|
| Lysophosphatidylcholines | 1 | 2020 | 81 | 0.180 |
Why?
|
| Aging | 7 | 2023 | 8664 | 0.180 |
Why?
|
| Family Health | 3 | 2021 | 1282 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 3 | 2020 | 377 | 0.180 |
Why?
|
| Hair Color | 3 | 2009 | 136 | 0.180 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2019 | 21 | 0.180 |
Why?
|
| Sphingomyelins | 1 | 2020 | 105 | 0.180 |
Why?
|
| Pseudouridine | 1 | 2020 | 24 | 0.180 |
Why?
|
| Tricarboxylic Acids | 2 | 2018 | 29 | 0.180 |
Why?
|
| Fibrinolytic Agents | 3 | 2016 | 2158 | 0.180 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 382 | 0.180 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 386 | 0.180 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2018 | 1366 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2011 | 299 | 0.180 |
Why?
|
| Selenium | 2 | 2014 | 405 | 0.180 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2011 | 284 | 0.170 |
Why?
|
| Body Weight | 5 | 2024 | 4669 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 2 | 2015 | 936 | 0.170 |
Why?
|
| Taste Perception | 1 | 2019 | 30 | 0.170 |
Why?
|
| Proteins | 9 | 2018 | 6103 | 0.170 |
Why?
|
| Membrane Glycoproteins | 4 | 2015 | 3768 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 3 | 2016 | 2647 | 0.170 |
Why?
|
| Radon | 1 | 2020 | 81 | 0.170 |
Why?
|
| Cooperative Behavior | 6 | 2016 | 1504 | 0.170 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2020 | 227 | 0.170 |
Why?
|
| Coronary Disease | 3 | 2015 | 6077 | 0.170 |
Why?
|
| Apolipoproteins E | 2 | 2019 | 1438 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2014 | 367 | 0.170 |
Why?
|
| Ceramides | 1 | 2020 | 199 | 0.170 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 2421 | 0.170 |
Why?
|
| Sex Characteristics | 7 | 2022 | 2585 | 0.170 |
Why?
|
| Kidney Neoplasms | 5 | 2019 | 4262 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2023 | 2916 | 0.170 |
Why?
|
| Internationality | 2 | 2022 | 1003 | 0.160 |
Why?
|
| Gene Regulatory Networks | 5 | 2020 | 1708 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2019 | 3143 | 0.160 |
Why?
|
| Particulate Matter | 3 | 2020 | 2530 | 0.160 |
Why?
|
| Twin Studies as Topic | 1 | 2018 | 105 | 0.160 |
Why?
|
| Phosphatidylcholines | 1 | 2020 | 411 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2018 | 5021 | 0.160 |
Why?
|
| PPAR alpha | 1 | 2020 | 197 | 0.160 |
Why?
|
| Survival Analysis | 11 | 2021 | 10252 | 0.160 |
Why?
|
| Polyps | 1 | 2020 | 189 | 0.160 |
Why?
|
| Kallikreins | 2 | 2011 | 258 | 0.160 |
Why?
|
| Microarray Analysis | 2 | 2019 | 767 | 0.160 |
Why?
|
| Nevus | 1 | 2020 | 204 | 0.160 |
Why?
|
| Blood Pressure | 4 | 2017 | 8554 | 0.160 |
Why?
|
| Testosterone | 4 | 2018 | 2420 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 6 | 2016 | 6171 | 0.160 |
Why?
|
| Schizophrenia | 4 | 2019 | 6882 | 0.160 |
Why?
|
| Epistasis, Genetic | 2 | 2011 | 365 | 0.160 |
Why?
|
| Arylalkylamine N-Acetyltransferase | 1 | 2017 | 12 | 0.160 |
Why?
|
| Aryldialkylphosphatase | 1 | 2017 | 63 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2014 | 437 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2016 | 133 | 0.150 |
Why?
|
| Reproducibility of Results | 17 | 2021 | 19905 | 0.150 |
Why?
|
| Heart Failure, Diastolic | 1 | 2018 | 69 | 0.150 |
Why?
|
| Vitamin B 12 | 3 | 2009 | 527 | 0.150 |
Why?
|
| alpha-Linolenic Acid | 2 | 2009 | 144 | 0.150 |
Why?
|
| Neoplasm Staging | 13 | 2021 | 11031 | 0.150 |
Why?
|
| Asparagus Plant | 1 | 2016 | 4 | 0.150 |
Why?
|
| Causality | 5 | 2023 | 1275 | 0.150 |
Why?
|
| Diabetes Mellitus | 5 | 2020 | 5751 | 0.150 |
Why?
|
| Genetic Heterogeneity | 5 | 2018 | 733 | 0.150 |
Why?
|
| Women's Health | 5 | 2016 | 2034 | 0.150 |
Why?
|
| Hypoglycemic Agents | 3 | 2023 | 2872 | 0.150 |
Why?
|
| Jews | 1 | 2019 | 385 | 0.150 |
Why?
|
| Oncogenes | 1 | 2023 | 1265 | 0.150 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 127 | 0.150 |
Why?
|
| Gout | 2 | 2015 | 573 | 0.150 |
Why?
|
| Longitudinal Studies | 9 | 2020 | 13989 | 0.150 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 381 | 0.150 |
Why?
|
| Mutation, Missense | 4 | 2023 | 2564 | 0.150 |
Why?
|
| Fecal Incontinence | 1 | 2019 | 239 | 0.150 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.150 |
Why?
|
| Keratin-13 | 1 | 2016 | 11 | 0.140 |
Why?
|
| Factor X | 1 | 2016 | 64 | 0.140 |
Why?
|
| Energy Intake | 4 | 2018 | 2148 | 0.140 |
Why?
|
| Heart Failure, Systolic | 1 | 2018 | 126 | 0.140 |
Why?
|
| Menopause, Premature | 2 | 2021 | 132 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 29 | 0.140 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2017 | 151 | 0.140 |
Why?
|
| Dimethylnitrosamine | 3 | 1981 | 16 | 0.140 |
Why?
|
| Biotinidase | 1 | 2016 | 19 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 5 | 2011 | 2716 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 1086 | 0.140 |
Why?
|
| Circadian Clocks | 2 | 2020 | 171 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2022 | 730 | 0.140 |
Why?
|
| TRPM Cation Channels | 1 | 2017 | 140 | 0.140 |
Why?
|
| Interleukin-6 | 4 | 2013 | 3200 | 0.140 |
Why?
|
| Tumor Burden | 2 | 2020 | 1915 | 0.140 |
Why?
|
| Young Adult | 25 | 2021 | 56430 | 0.140 |
Why?
|
| Zebrafish Proteins | 1 | 2003 | 1005 | 0.140 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 2 | 2013 | 12 | 0.140 |
Why?
|
| Prothrombin | 1 | 2016 | 185 | 0.140 |
Why?
|
| Keratin-6 | 1 | 2015 | 18 | 0.140 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Exfoliation Syndrome | 1 | 2017 | 110 | 0.140 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2356 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2016 | 4554 | 0.140 |
Why?
|
| Keratin-5 | 1 | 2015 | 46 | 0.140 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 36 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2016 | 161 | 0.140 |
Why?
|
| Steroid Hydroxylases | 2 | 2013 | 96 | 0.140 |
Why?
|
| Hemostasis | 2 | 2016 | 458 | 0.140 |
Why?
|
| Epigenesis, Genetic | 4 | 2016 | 3647 | 0.140 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 112 | 0.140 |
Why?
|
| Dairy Products | 1 | 2019 | 498 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 3047 | 0.140 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2016 | 110 | 0.130 |
Why?
|
| Chromosome Aberrations | 4 | 2015 | 1813 | 0.130 |
Why?
|
| Stroke | 2 | 2017 | 9981 | 0.130 |
Why?
|
| OX40 Ligand | 1 | 2015 | 51 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 67 | 0.130 |
Why?
|
| HLA Antigens | 3 | 2019 | 1381 | 0.130 |
Why?
|
| Keratinocytes | 2 | 2017 | 798 | 0.130 |
Why?
|
| Waist Circumference | 3 | 2015 | 917 | 0.130 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 91 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2023 | 980 | 0.130 |
Why?
|
| Serine Endopeptidases | 2 | 2023 | 1072 | 0.130 |
Why?
|
| Membrane Transport Proteins | 4 | 2015 | 1028 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 3 | 2018 | 270 | 0.130 |
Why?
|
| Genome | 4 | 2012 | 1808 | 0.130 |
Why?
|
| Health Personnel | 6 | 2024 | 3218 | 0.130 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 340 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.130 |
Why?
|
| Microsatellite Instability | 2 | 2017 | 684 | 0.130 |
Why?
|
| Twins, Dizygotic | 1 | 2016 | 236 | 0.130 |
Why?
|
| Caveolin 1 | 2 | 2014 | 263 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 1676 | 0.130 |
Why?
|
| Hypolipidemic Agents | 1 | 2020 | 604 | 0.130 |
Why?
|
| Inflammation | 7 | 2021 | 10638 | 0.130 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2015 | 77 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2019 | 496 | 0.130 |
Why?
|
| Adolescent | 30 | 2021 | 85781 | 0.130 |
Why?
|
| Urine | 1 | 2016 | 370 | 0.130 |
Why?
|
| Circadian Rhythm | 3 | 2017 | 2624 | 0.130 |
Why?
|
| Point Mutation | 2 | 2017 | 1623 | 0.130 |
Why?
|
| Interleukin-15 | 1 | 2015 | 184 | 0.130 |
Why?
|
| Dyssomnias | 1 | 2014 | 29 | 0.130 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.130 |
Why?
|
| Repressor Proteins | 4 | 2019 | 3023 | 0.120 |
Why?
|
| Cognition | 3 | 2019 | 6770 | 0.120 |
Why?
|
| Meat | 2 | 2014 | 592 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 3 | 2014 | 577 | 0.120 |
Why?
|
| Blood Specimen Collection | 1 | 2016 | 246 | 0.120 |
Why?
|
| Parents | 5 | 2020 | 3407 | 0.120 |
Why?
|
| Acetyl Coenzyme A | 1 | 2014 | 74 | 0.120 |
Why?
|
| Agouti Signaling Protein | 2 | 2011 | 21 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2014 | 1881 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 222 | 0.120 |
Why?
|
| Spirometry | 1 | 2017 | 864 | 0.120 |
Why?
|
| Apolipoprotein E2 | 1 | 2014 | 127 | 0.120 |
Why?
|
| Caveolin 2 | 1 | 2013 | 25 | 0.120 |
Why?
|
| Twins, Monozygotic | 1 | 2016 | 458 | 0.120 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 236 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2013 | 374 | 0.120 |
Why?
|
| beta Catenin | 2 | 2013 | 1059 | 0.120 |
Why?
|
| High Mobility Group Proteins | 2 | 2012 | 187 | 0.120 |
Why?
|
| Cyclin E | 1 | 2014 | 172 | 0.120 |
Why?
|
| Organ Size | 1 | 2019 | 2252 | 0.120 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 654 | 0.120 |
Why?
|
| Adenoma | 2 | 2020 | 2174 | 0.120 |
Why?
|
| Ocular Physiological Phenomena | 1 | 2014 | 70 | 0.120 |
Why?
|
| Coronary Artery Disease | 5 | 2018 | 6487 | 0.120 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 319 | 0.120 |
Why?
|
| Puberty | 1 | 2017 | 490 | 0.120 |
Why?
|
| Domperidone | 1 | 2013 | 23 | 0.120 |
Why?
|
| Aspirin | 2 | 2017 | 3282 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1114 | 0.120 |
Why?
|
| Casein Kinase II | 1 | 2014 | 128 | 0.120 |
Why?
|
| Beverages | 1 | 2019 | 820 | 0.120 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 846 | 0.120 |
Why?
|
| Testicular Neoplasms | 2 | 2017 | 804 | 0.120 |
Why?
|
| Genealogy and Heraldry | 1 | 2013 | 28 | 0.120 |
Why?
|
| Osteoarthritis | 1 | 2021 | 1036 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 1475 | 0.110 |
Why?
|
| Publishing | 2 | 2011 | 833 | 0.110 |
Why?
|
| Lipids | 6 | 2022 | 3305 | 0.110 |
Why?
|
| Genomic Structural Variation | 1 | 2013 | 64 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2290 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2016 | 1341 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 627 | 0.110 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
| Air Pollutants | 4 | 2020 | 2817 | 0.110 |
Why?
|
| Phospholipase D | 1 | 2013 | 70 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2016 | 810 | 0.110 |
Why?
|
| Chronic Disease | 5 | 2018 | 9146 | 0.110 |
Why?
|
| Iron | 1 | 2021 | 1774 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2017 | 721 | 0.110 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 789 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2015 | 3870 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 3 | 2012 | 2494 | 0.110 |
Why?
|
| Myositis | 1 | 2015 | 251 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3255 | 0.110 |
Why?
|
| Lod Score | 2 | 2003 | 614 | 0.110 |
Why?
|
| Selenoproteins | 2 | 2014 | 216 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 66 | 0.110 |
Why?
|
| Trichomonas Infections | 1 | 2012 | 43 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2016 | 3923 | 0.110 |
Why?
|
| Bone Neoplasms | 3 | 2015 | 2529 | 0.110 |
Why?
|
| Estradiol | 4 | 2014 | 2020 | 0.110 |
Why?
|
| Blood Glucose | 5 | 2022 | 6256 | 0.110 |
Why?
|
| Dyslipidemias | 1 | 2020 | 849 | 0.110 |
Why?
|
| Hodgkin Disease | 2 | 2011 | 1415 | 0.100 |
Why?
|
| Homeostasis | 1 | 2023 | 3340 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2017 | 1402 | 0.100 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 251 | 0.100 |
Why?
|
| Hyperuricemia | 1 | 2015 | 211 | 0.100 |
Why?
|
| Perception | 2 | 2015 | 1198 | 0.100 |
Why?
|
| Carbon | 2 | 2013 | 687 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 253 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2023 | 1581 | 0.100 |
Why?
|
| Pulmonary Embolism | 2 | 2018 | 2376 | 0.100 |
Why?
|
| Diuretics | 1 | 2015 | 592 | 0.100 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2011 | 98 | 0.100 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 235 | 0.100 |
Why?
|
| Myocardial Infarction | 5 | 2016 | 11727 | 0.100 |
Why?
|
| Norway | 3 | 2016 | 448 | 0.100 |
Why?
|
| Adipose Tissue | 6 | 2016 | 3279 | 0.100 |
Why?
|
| Genetic Phenomena | 1 | 2011 | 5 | 0.100 |
Why?
|
| Confidence Intervals | 5 | 2012 | 2971 | 0.100 |
Why?
|
| CpG Islands | 3 | 2020 | 1172 | 0.100 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2016 | 518 | 0.100 |
Why?
|
| Methionine | 2 | 2011 | 590 | 0.100 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 15 | 0.100 |
Why?
|
| Costa Rica | 5 | 2009 | 177 | 0.100 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2012 | 315 | 0.100 |
Why?
|
| Osteosarcoma | 2 | 2015 | 881 | 0.100 |
Why?
|
| Glycine | 1 | 2014 | 671 | 0.100 |
Why?
|
| Ferritins | 1 | 2014 | 590 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2013 | 463 | 0.100 |
Why?
|
| Physical Chromosome Mapping | 1 | 2011 | 183 | 0.100 |
Why?
|
| Nuclear Proteins | 5 | 2022 | 5853 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 270 | 0.100 |
Why?
|
| Models, Biological | 5 | 2019 | 9583 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2021 | 115 | 0.100 |
Why?
|
| Hydro-Lyases | 1 | 2010 | 94 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2014 | 8324 | 0.090 |
Why?
|
| Amide Synthases | 1 | 2010 | 12 | 0.090 |
Why?
|
| Drinking Behavior | 1 | 2011 | 103 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2014 | 6365 | 0.090 |
Why?
|
| Data Collection | 2 | 2018 | 3341 | 0.090 |
Why?
|
| Laminin | 1 | 2012 | 419 | 0.090 |
Why?
|
| Calcium | 3 | 2023 | 5756 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2010 | 58 | 0.090 |
Why?
|
| Lymphoma, Follicular | 1 | 2014 | 435 | 0.090 |
Why?
|
| Child | 19 | 2023 | 77709 | 0.090 |
Why?
|
| Behavior, Addictive | 1 | 2016 | 462 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2017 | 12208 | 0.090 |
Why?
|
| Motivation | 2 | 2013 | 1971 | 0.090 |
Why?
|
| Antiporters | 2 | 2009 | 277 | 0.090 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2133 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2016 | 594 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
| China | 2 | 2013 | 2248 | 0.090 |
Why?
|
| Periodontitis | 1 | 2015 | 553 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2282 | 0.090 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2017 | 546 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 4 | 2021 | 3616 | 0.090 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2023 | 293 | 0.090 |
Why?
|
| RNA | 2 | 2018 | 2749 | 0.090 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 15076 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 1063 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2017 | 4026 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2010 | 2938 | 0.090 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2009 | 25 | 0.090 |
Why?
|
| Folic Acid | 3 | 2011 | 1300 | 0.090 |
Why?
|
| Prescription Drugs | 1 | 2016 | 595 | 0.090 |
Why?
|
| Registries | 5 | 2020 | 8089 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2016 | 2849 | 0.090 |
Why?
|
| Carcinoma in Situ | 1 | 2015 | 806 | 0.090 |
Why?
|
| Dietary Carbohydrates | 2 | 2017 | 906 | 0.090 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2009 | 2499 | 0.080 |
Why?
|
| Air Pollution | 2 | 2020 | 2286 | 0.080 |
Why?
|
| Vitamin B Complex | 1 | 2011 | 288 | 0.080 |
Why?
|
| Nuclear Family | 2 | 2000 | 318 | 0.080 |
Why?
|
| Quality Control | 4 | 2014 | 841 | 0.080 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2008 | 22 | 0.080 |
Why?
|
| Genome, Mitochondrial | 1 | 2009 | 71 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 690 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1563 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 140 | 0.080 |
Why?
|
| Multiple Sclerosis | 2 | 2015 | 3079 | 0.080 |
Why?
|
| Mass Screening | 2 | 2022 | 5255 | 0.080 |
Why?
|
| Actins | 1 | 2016 | 2121 | 0.080 |
Why?
|
| Sunbathing | 1 | 2009 | 60 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 249 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1821 | 0.080 |
Why?
|
| Marriage | 1 | 2010 | 339 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2009 | 287 | 0.080 |
Why?
|
| Population Surveillance | 5 | 2019 | 2616 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2018 | 2915 | 0.080 |
Why?
|
| Bipolar Disorder | 2 | 2023 | 5027 | 0.080 |
Why?
|
| Disclosure | 2 | 2011 | 736 | 0.080 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2008 | 54 | 0.080 |
Why?
|
| Fucosyltransferases | 1 | 2008 | 119 | 0.080 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2007 | 12 | 0.080 |
Why?
|
| Work Schedule Tolerance | 1 | 2012 | 565 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 1121 | 0.080 |
Why?
|
| Fats | 1 | 2008 | 102 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1378 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2021 | 6538 | 0.080 |
Why?
|
| DNA | 3 | 2019 | 7301 | 0.080 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 48 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 1018 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2017 | 2050 | 0.080 |
Why?
|
| Animals | 23 | 2023 | 168757 | 0.080 |
Why?
|
| Heart Rate | 2 | 2023 | 4091 | 0.080 |
Why?
|
| One-Carbon Group Transferases | 1 | 2007 | 6 | 0.080 |
Why?
|
| Time Factors | 11 | 2021 | 40075 | 0.080 |
Why?
|
| Insulin Resistance | 4 | 2017 | 3864 | 0.080 |
Why?
|
| E-Selectin | 1 | 2010 | 579 | 0.080 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 1364 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 1504 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2008 | 245 | 0.070 |
Why?
|
| Japan | 1 | 2011 | 1360 | 0.070 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2008 | 224 | 0.070 |
Why?
|
| Carnitine | 2 | 2018 | 246 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 611 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1663 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2015 | 893 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2899 | 0.070 |
Why?
|
| Checklist | 2 | 2011 | 833 | 0.070 |
Why?
|
| Uric Acid | 1 | 2012 | 766 | 0.070 |
Why?
|
| Vitamin E | 1 | 2011 | 869 | 0.070 |
Why?
|
| Insulin | 4 | 2022 | 6580 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 882 | 0.070 |
Why?
|
| Visual Fields | 1 | 2013 | 1047 | 0.070 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 86 | 0.070 |
Why?
|
| Microfilament Proteins | 3 | 2019 | 1152 | 0.070 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2006 | 13 | 0.070 |
Why?
|
| Caffeine | 1 | 2011 | 699 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2023 | 9959 | 0.070 |
Why?
|
| Glycemic Index | 1 | 2009 | 395 | 0.070 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 350 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 225 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2715 | 0.070 |
Why?
|
| Receptor, erbB-2 | 3 | 2022 | 2416 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2013 | 1058 | 0.070 |
Why?
|
| MicroRNAs | 3 | 2018 | 3752 | 0.070 |
Why?
|
| Lung | 3 | 2019 | 9856 | 0.070 |
Why?
|
| Trinucleotide Repeats | 3 | 2014 | 261 | 0.070 |
Why?
|
| Biosynthetic Pathways | 1 | 2006 | 137 | 0.070 |
Why?
|
| C-Reactive Protein | 3 | 2018 | 3778 | 0.070 |
Why?
|
| Rad51 Recombinase | 2 | 2018 | 189 | 0.070 |
Why?
|
| Warfarin | 1 | 2014 | 1496 | 0.070 |
Why?
|
| Eating | 2 | 2013 | 1536 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 891 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 275 | 0.070 |
Why?
|
| Immunity | 1 | 2012 | 1012 | 0.070 |
Why?
|
| Adipokines | 2 | 2023 | 319 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2016 | 880 | 0.070 |
Why?
|
| Introns | 3 | 2017 | 991 | 0.070 |
Why?
|
| Steroids | 1 | 2010 | 930 | 0.070 |
Why?
|
| Hypertension | 3 | 2019 | 8480 | 0.070 |
Why?
|
| Sperm Count | 1 | 2006 | 216 | 0.060 |
Why?
|
| Selection, Genetic | 2 | 2023 | 914 | 0.060 |
Why?
|
| Wnt Proteins | 2 | 2013 | 721 | 0.060 |
Why?
|
| Choice Behavior | 1 | 2011 | 803 | 0.060 |
Why?
|
| Ozone | 2 | 2006 | 469 | 0.060 |
Why?
|
| Epidemiology | 1 | 2007 | 287 | 0.060 |
Why?
|
| Platelet Activation | 2 | 2023 | 673 | 0.060 |
Why?
|
| Indoles | 1 | 2013 | 1839 | 0.060 |
Why?
|
| Cotinine | 2 | 2017 | 206 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2734 | 0.060 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 2690 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5034 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 1239 | 0.060 |
Why?
|
| Poisson Distribution | 1 | 2006 | 513 | 0.060 |
Why?
|
| Glaucoma | 1 | 2014 | 1159 | 0.060 |
Why?
|
| Prolactin | 2 | 2018 | 669 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 493 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1373 | 0.060 |
Why?
|
| Self Report | 4 | 2018 | 3558 | 0.060 |
Why?
|
| Celiac Disease | 1 | 2012 | 785 | 0.060 |
Why?
|
| Pharmacogenetics | 2 | 2020 | 675 | 0.060 |
Why?
|
| Acute Disease | 1 | 2014 | 7149 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 328 | 0.060 |
Why?
|
| Iceland | 2 | 2014 | 183 | 0.060 |
Why?
|
| Interleukins | 1 | 2008 | 791 | 0.060 |
Why?
|
| Cholesterol | 2 | 2016 | 2917 | 0.060 |
Why?
|
| Body Size | 3 | 2011 | 461 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 376 | 0.060 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 949 | 0.060 |
Why?
|
| Anxiety | 1 | 2018 | 4297 | 0.060 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 16689 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 1832 | 0.060 |
Why?
|
| Receptors, Adiponectin | 1 | 2023 | 81 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3265 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2004 | 255 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 497 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2268 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1912 | 0.050 |
Why?
|
| Cations | 1 | 2023 | 232 | 0.050 |
Why?
|
| Survival Rate | 5 | 2017 | 12788 | 0.050 |
Why?
|
| Pregnancy | 5 | 2020 | 29144 | 0.050 |
Why?
|
| Matched-Pair Analysis | 2 | 2000 | 288 | 0.050 |
Why?
|
| Eczema | 1 | 2005 | 231 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21827 | 0.050 |
Why?
|
| Health Surveys | 3 | 2020 | 4037 | 0.050 |
Why?
|
| Binding Sites | 3 | 2017 | 6114 | 0.050 |
Why?
|
| Longevity | 2 | 2021 | 1070 | 0.050 |
Why?
|
| Disease Progression | 6 | 2016 | 13284 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3798 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2303 | 0.050 |
Why?
|
| Dioxygenases | 2 | 2014 | 316 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2003 | 188 | 0.050 |
Why?
|
| Quality of Life | 2 | 2023 | 12804 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 669 | 0.050 |
Why?
|
| Linoleic Acid | 2 | 2017 | 157 | 0.050 |
Why?
|
| Mice | 11 | 2023 | 81183 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2016 | 380 | 0.050 |
Why?
|
| Cyclin T | 1 | 2021 | 20 | 0.050 |
Why?
|
| T-Box Domain Proteins | 2 | 2016 | 471 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 4456 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2016 | 604 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2003 | 338 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1357 | 0.050 |
Why?
|
| Selection Bias | 1 | 2023 | 371 | 0.050 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2013 | 154 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2009 | 3508 | 0.050 |
Why?
|
| Calcium Channels | 2 | 2017 | 622 | 0.050 |
Why?
|
| Intention | 1 | 2024 | 341 | 0.050 |
Why?
|
| Asthma | 1 | 2020 | 6011 | 0.050 |
Why?
|
| Gene Dosage | 3 | 2010 | 1252 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1889 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1081 | 0.050 |
Why?
|
| Genes, BRCA1 | 1 | 2004 | 781 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 117 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2018 | 581 | 0.050 |
Why?
|
| Population Groups | 1 | 2021 | 209 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 1861 | 0.050 |
Why?
|
| Factor XIII | 1 | 2020 | 59 | 0.050 |
Why?
|
| Sweden | 2 | 2016 | 1345 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2023 | 798 | 0.040 |
Why?
|
| Cross-Sectional Studies | 6 | 2020 | 25043 | 0.040 |
Why?
|
| Magnesium | 1 | 2023 | 813 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2017 | 13033 | 0.040 |
Why?
|
| Mifepristone | 1 | 2000 | 150 | 0.040 |
Why?
|
| Connecticut | 2 | 2011 | 366 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5535 | 0.040 |
Why?
|
| Obesity, Abdominal | 1 | 2023 | 361 | 0.040 |
Why?
|
| Motor Activity | 3 | 2016 | 2714 | 0.040 |
Why?
|
| Age Distribution | 2 | 2016 | 2902 | 0.040 |
Why?
|
| Prostate | 2 | 2022 | 1774 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 245 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2023 | 618 | 0.040 |
Why?
|
| Beer | 1 | 2019 | 127 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2019 | 195 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2020 | 100 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 140 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 63114 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2018 | 14 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 2014 | 970 | 0.040 |
Why?
|
| Food | 2 | 2016 | 771 | 0.040 |
Why?
|
| Wine | 1 | 2019 | 165 | 0.040 |
Why?
|
| Sleep | 1 | 2014 | 4623 | 0.040 |
Why?
|
| Germany | 1 | 2021 | 862 | 0.040 |
Why?
|
| Prevalence | 5 | 2016 | 15226 | 0.040 |
Why?
|
| DNA Repair Enzymes | 2 | 2012 | 349 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2019 | 237 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2004 | 903 | 0.040 |
Why?
|
| Comorbidity | 3 | 2023 | 10388 | 0.040 |
Why?
|
| Diglycerides | 1 | 2018 | 176 | 0.040 |
Why?
|
| Hypoxanthine | 1 | 2018 | 28 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2005 | 636 | 0.040 |
Why?
|
| Low Tension Glaucoma | 1 | 2018 | 22 | 0.040 |
Why?
|
| Women | 1 | 2020 | 230 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2018 | 219 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2000 | 477 | 0.040 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2017 | 19 | 0.040 |
Why?
|
| Weight Gain | 1 | 2008 | 2292 | 0.040 |
Why?
|
| Cause of Death | 2 | 2021 | 3584 | 0.040 |
Why?
|
| Telomere-Binding Proteins | 1 | 2018 | 116 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2017 | 50 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4186 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 246 | 0.040 |
Why?
|
| Fasting | 2 | 2017 | 1593 | 0.040 |
Why?
|
| Synaptophysin | 1 | 2017 | 141 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 694 | 0.040 |
Why?
|
| Tea | 1 | 2019 | 275 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 118 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2017 | 4933 | 0.040 |
Why?
|
| Educational Status | 2 | 2016 | 2540 | 0.040 |
Why?
|
| Vocabulary | 1 | 2018 | 169 | 0.040 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 128 | 0.040 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6895 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2017 | 127 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2008 | 2924 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5442 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 2019 | 247 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2009 | 535 | 0.040 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2020 | 271 | 0.040 |
Why?
|
| Calcifediol | 1 | 2018 | 166 | 0.040 |
Why?
|
| Inosine | 1 | 2018 | 133 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 1171 | 0.040 |
Why?
|
| Workflow | 1 | 2022 | 847 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2000 | 641 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2003 | 1364 | 0.040 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1998 | 166 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 949 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2020 | 2866 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2016 | 1157 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 711 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2016 | 7 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2018 | 169 | 0.040 |
Why?
|
| Fanconi Anemia | 1 | 2019 | 319 | 0.040 |
Why?
|
| Microvascular Angina | 1 | 1996 | 15 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 2025 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2019 | 77449 | 0.040 |
Why?
|
| Canada | 1 | 2022 | 2065 | 0.040 |
Why?
|
| Sweetening Agents | 1 | 2019 | 296 | 0.040 |
Why?
|
| Cyclophilins | 1 | 2016 | 46 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 18029 | 0.040 |
Why?
|
| Aconitic Acid | 1 | 2016 | 14 | 0.040 |
Why?
|
| Isocitrates | 1 | 2016 | 24 | 0.030 |
Why?
|
| Sudan | 1 | 2016 | 83 | 0.030 |
Why?
|
| Base Sequence | 3 | 2019 | 12797 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8037 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 450 | 0.030 |
Why?
|
| Histones | 2 | 2017 | 2599 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 2 | 2015 | 1602 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 2 | 2012 | 977 | 0.030 |
Why?
|
| Oxidative Stress | 3 | 2015 | 3086 | 0.030 |
Why?
|
| Asia | 1 | 2017 | 610 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 3505 | 0.030 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2015 | 26 | 0.030 |
Why?
|
| Simvastatin | 1 | 2018 | 360 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1903 | 0.030 |
Why?
|
| Child, Preschool | 6 | 2016 | 41006 | 0.030 |
Why?
|
| Porphyrins | 1 | 2018 | 348 | 0.030 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 2214 | 0.030 |
Why?
|
| Chemokines | 1 | 2020 | 970 | 0.030 |
Why?
|
| Translocation, Genetic | 2 | 1998 | 1420 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2016 | 14557 | 0.030 |
Why?
|
| Muscles | 1 | 2000 | 1614 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 351 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1906 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 403 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2003 | 2617 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1224 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 10943 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 290 | 0.030 |
Why?
|
| Coffee | 1 | 2019 | 578 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2016 | 236 | 0.030 |
Why?
|
| Smell | 1 | 2016 | 244 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2017 | 8436 | 0.030 |
Why?
|
| Finland | 1 | 2016 | 602 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 209 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 594 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 238 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 68 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2016 | 355 | 0.030 |
Why?
|
| Dynamin II | 1 | 2014 | 35 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 588 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 378 | 0.030 |
Why?
|
| Serpins | 1 | 2016 | 247 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1866 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 58 | 0.030 |
Why?
|
| Receptor, Endothelin B | 1 | 2014 | 41 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2014 | 84 | 0.030 |
Why?
|
| Chromatin | 2 | 2018 | 2934 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 58 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 18111 | 0.030 |
Why?
|
| Mathematical Computing | 1 | 2014 | 147 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 728 | 0.030 |
Why?
|
| Child Mortality | 1 | 2016 | 198 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2001 | 1873 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.030 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2014 | 238 | 0.030 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2013 | 11 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 802 | 0.030 |
Why?
|
| Liver | 3 | 2018 | 7474 | 0.030 |
Why?
|
| Eye Color | 1 | 2013 | 36 | 0.030 |
Why?
|
| Denmark | 1 | 2016 | 738 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2046 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 133 | 0.030 |
Why?
|
| Mothers | 1 | 2004 | 2165 | 0.030 |
Why?
|
| Public Policy | 1 | 1998 | 572 | 0.030 |
Why?
|
| Dynamins | 1 | 2014 | 152 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1085 | 0.030 |
Why?
|
| Vitamins | 2 | 2012 | 1622 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 2009 | 1758 | 0.030 |
Why?
|
| Intelligence | 1 | 2018 | 920 | 0.030 |
Why?
|
| Xanthophylls | 1 | 2012 | 96 | 0.030 |
Why?
|
| Eye | 1 | 2017 | 729 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1351 | 0.030 |
Why?
|
| Neuromyelitis Optica | 1 | 2016 | 252 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 802 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4665 | 0.030 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 104 | 0.030 |
Why?
|
| Nails | 1 | 2014 | 292 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 453 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 300 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 157 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 742 | 0.030 |
Why?
|
| HLA-DQ Antigens | 1 | 2012 | 210 | 0.030 |
Why?
|
| Mexico | 1 | 2014 | 690 | 0.030 |
Why?
|
| Lutein | 1 | 2012 | 125 | 0.030 |
Why?
|
| Piperidines | 1 | 2000 | 1602 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1791 | 0.030 |
Why?
|
| Trichomonas vaginalis | 1 | 2012 | 76 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 315 | 0.030 |
Why?
|
| Inhibins | 1 | 2012 | 211 | 0.030 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2012 | 119 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2012 | 146 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 3610 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1142 | 0.030 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2012 | 150 | 0.030 |
Why?
|
| Vegetables | 1 | 2017 | 1182 | 0.030 |
Why?
|
| Exons | 2 | 2008 | 2437 | 0.030 |
Why?
|
| Diet, Mediterranean | 1 | 2018 | 700 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 142 | 0.030 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 30 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2018 | 1534 | 0.030 |
Why?
|
| Calibration | 1 | 2014 | 816 | 0.030 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2011 | 29 | 0.030 |
Why?
|
| Exosomes | 1 | 2016 | 417 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 975 | 0.030 |
Why?
|
| Pakistan | 1 | 2012 | 295 | 0.030 |
Why?
|
| Thymidylate Synthase | 1 | 2011 | 75 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5221 | 0.030 |
Why?
|
| Reaction Time | 1 | 2018 | 2097 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 109 | 0.020 |
Why?
|
| Work | 1 | 2012 | 191 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 401 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 379 | 0.020 |
Why?
|
| beta Carotene | 1 | 2012 | 527 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 689 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1655 | 0.020 |
Why?
|
| Androgens | 2 | 2011 | 1281 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 733 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2012 | 178 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 1992 | 492 | 0.020 |
Why?
|
| Progestins | 1 | 2013 | 306 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2171 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 5181 | 0.020 |
Why?
|
| Life Change Events | 1 | 2016 | 938 | 0.020 |
Why?
|
| Religion | 1 | 2014 | 356 | 0.020 |
Why?
|
| Benzyl Compounds | 2 | 1980 | 20 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 180 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2575 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 611 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 114 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2010 | 73 | 0.020 |
Why?
|
| Pigmentation | 1 | 2011 | 148 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2017 | 3144 | 0.020 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 154 | 0.020 |
Why?
|
| Research Report | 1 | 2013 | 355 | 0.020 |
Why?
|
| Cyprus | 1 | 2010 | 79 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2012 | 354 | 0.020 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2010 | 104 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
| Piperazines | 1 | 2000 | 2488 | 0.020 |
Why?
|
| Samoa | 1 | 2009 | 6 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2010 | 113 | 0.020 |
Why?
|
| Somatomedins | 1 | 2010 | 192 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 147 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 2 | 1980 | 380 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 121 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2009 | 2751 | 0.020 |
Why?
|
| Caspase 10 | 1 | 2009 | 4 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 1125 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 1992 | 299 | 0.020 |
Why?
|
| Puberty, Delayed | 1 | 2010 | 115 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2017 | 1226 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 3848 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 976 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 3462 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2010 | 194 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2009 | 62 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2012 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1076 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Glucose | 2 | 2012 | 4397 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 1352 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 1677 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 92 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2010 | 156 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 209 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2012 | 278 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2016 | 2539 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1150 | 0.020 |
Why?
|
| Integrins | 1 | 2013 | 846 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 1519 | 0.020 |
Why?
|
| Proprotein Convertases | 1 | 2009 | 95 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 1992 | 403 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 486 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2009 | 206 | 0.020 |
Why?
|
| Interleukin-16 | 1 | 2008 | 33 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2008 | 58 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1940 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2016 | 3913 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 503 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3128 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2013 | 1586 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2014 | 1172 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 444 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 780 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1992 | 822 | 0.020 |
Why?
|
| Education | 1 | 2011 | 543 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2007 | 156 | 0.020 |
Why?
|
| Thrombophilia | 1 | 2010 | 305 | 0.020 |
Why?
|
| India | 1 | 2014 | 2197 | 0.020 |
Why?
|
| Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 4986 | 0.020 |
Why?
|
| Calcium Channels, T-Type | 1 | 2007 | 34 | 0.020 |
Why?
|
| Transcobalamins | 1 | 2007 | 18 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2010 | 400 | 0.020 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1025 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4420 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2007 | 56 | 0.020 |
Why?
|
| Infant | 4 | 2016 | 35136 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2001 | 5317 | 0.020 |
Why?
|
| Nicotine | 1 | 2012 | 681 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2948 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1047 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 242 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2023 | 4558 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2009 | 424 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1157 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2008 | 272 | 0.020 |
Why?
|
| Substance-Related Disorders | 2 | 2016 | 4258 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1692 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2010 | 530 | 0.020 |
Why?
|
| Social Class | 1 | 2016 | 1999 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2014 | 7729 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2892 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15997 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 537 | 0.020 |
Why?
|
| Health Occupations | 1 | 2008 | 224 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2015 | 19229 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 514 | 0.020 |
Why?
|
| Lipolysis | 1 | 2007 | 210 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 859 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 648 | 0.020 |
Why?
|
| Seasons | 1 | 2012 | 1493 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1041 | 0.020 |
Why?
|
| New Hampshire | 1 | 2006 | 172 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 690 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 1997 | 7785 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2011 | 12026 | 0.020 |
Why?
|
| Mitochondria | 1 | 2019 | 3520 | 0.020 |
Why?
|
| Karyotyping | 2 | 1998 | 1243 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2007 | 271 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2007 | 344 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 2432 | 0.020 |
Why?
|
| Los Angeles | 1 | 2006 | 238 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 31 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2019 | 3209 | 0.020 |
Why?
|
| Color | 1 | 2006 | 307 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 6993 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5974 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 950 | 0.020 |
Why?
|
| Sunburn | 1 | 2006 | 155 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 2009 | 760 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2006 | 262 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2010 | 2297 | 0.020 |
Why?
|
| Sunlight | 1 | 2006 | 325 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 890 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5524 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2009 | 582 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2008 | 1173 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 1405 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2886 | 0.010 |
Why?
|
| Anthropometry | 1 | 2008 | 1350 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 817 | 0.010 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2003 | 40 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 2004 | 112 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9727 | 0.010 |
Why?
|
| Nitrogen Dioxide | 1 | 2006 | 490 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 7023 | 0.010 |
Why?
|
| Hair | 1 | 2006 | 483 | 0.010 |
Why?
|
| Adult Children | 1 | 2003 | 100 | 0.010 |
Why?
|
| Cadherins | 1 | 2008 | 907 | 0.010 |
Why?
|
| Immunophenotyping | 2 | 1998 | 1880 | 0.010 |
Why?
|
| Dust | 1 | 2006 | 482 | 0.010 |
Why?
|
| Leucine | 1 | 2004 | 561 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2013 | 2925 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2011 | 1099 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4364 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 2006 | 531 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 617 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 1912 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 2007 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2003 | 211 | 0.010 |
Why?
|
| New England | 1 | 2005 | 1022 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 1213 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3309 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9239 | 0.010 |
Why?
|
| Health Behavior | 1 | 2013 | 2636 | 0.010 |
Why?
|
| Emotions | 1 | 2013 | 2661 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2010 | 2035 | 0.010 |
Why?
|
| Adipocytes | 1 | 2008 | 1184 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1996 | 4245 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2006 | 1060 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1730 | 0.010 |
Why?
|
| Levonorgestrel | 1 | 2000 | 77 | 0.010 |
Why?
|
| Public Health | 1 | 2013 | 2603 | 0.010 |
Why?
|
| Lac Operon | 1 | 2000 | 238 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3772 | 0.010 |
Why?
|
| Densitometry | 1 | 1980 | 156 | 0.010 |
Why?
|
| Ovulation | 1 | 2000 | 189 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2000 | 459 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 425 | 0.010 |
Why?
|
| Rats | 3 | 1981 | 24260 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2006 | 1414 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 2186 | 0.010 |
Why?
|
| Autoradiography | 1 | 1980 | 745 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6622 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1992 | 3110 | 0.010 |
Why?
|
| Drug Compounding | 1 | 2000 | 242 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 1463 | 0.010 |
Why?
|
| Pyridazines | 1 | 2000 | 202 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6314 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6600 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2000 | 302 | 0.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2009 | 2043 | 0.010 |
Why?
|
| Internet | 1 | 2011 | 3064 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2440 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 666 | 0.010 |
Why?
|
| Overweight | 1 | 2010 | 2371 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 772 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2000 | 915 | 0.010 |
Why?
|
| Boston | 1 | 2011 | 9313 | 0.010 |
Why?
|
| Life Tables | 1 | 1998 | 370 | 0.010 |
Why?
|
| Endometrium | 1 | 2000 | 424 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1998 | 203 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 865 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1801 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8663 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1980 | 2327 | 0.010 |
Why?
|
| Brain | 2 | 2016 | 26385 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 804 | 0.010 |
Why?
|
| Myocardium | 1 | 2008 | 4776 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5172 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 514 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2000 | 2716 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15540 | 0.010 |
Why?
|
| Feces | 1 | 1980 | 1401 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 4894 | 0.010 |
Why?
|
| Critical Care | 1 | 2007 | 2647 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11483 | 0.010 |
Why?
|
| Macrophages | 1 | 2008 | 5655 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4568 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 279 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 35421 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 2942 | 0.010 |
Why?
|
| Protein Binding | 1 | 2000 | 9386 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1992 | 1354 | 0.000 |
Why?
|
| Myocardial Ischemia | 1 | 1996 | 2148 | 0.000 |
Why?
|
| Kidney | 1 | 1980 | 7186 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1992 | 4776 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1992 | 4397 | 0.000 |
Why?
|